1.66 +0.02 (1.20%)
PARD
Stock Details
Last Trade:1.66 Change:+0.02 (1.20%) Prev Close:1.64 Open: 1.66 Days Range:1.60 – 1.70 52 Week Range: 1.50 - 9.14 Volume:1335891 P/E: N/AEPS:-1.35
View AllRecent Alerts 02/09/10
Recent Alert on 02/03/10 at 12:34pm
Poniard Pharma (PARD) Names Martell as New CEO, Succeeding McMahon; to Reduce Workforce by 21 Employees
Poniard Pharma (PARD) Names Martell as New CEO, Succeeding McMahon; to Reduce Workforce by 21 Employees
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD) today announced that Ronald Martell has been appointed to the position of CEO, succeeding Jerry McMahon, Ph.D., who will remain as non-executive chairman of the Board of Directors. In addition, Michael... Read More
Recent Alert on 02/03/10 at 12:34pm
Poniard Pharma (PARD) Names Martell as New CEO, Succeeding McMahon; to Reduce Workforce by 21 Employees
Poniard Pharma (PARD) Names Martell as New CEO, Succeeding McMahon; to Reduce Workforce by 21 Employees
Recent Alert on 01/25/10 at 1:13pm
Unusual 11 Mid-Day Movers 1/25: SMTX, NBS, KFS, SILC, PVTB Higher; PARD, ZAGG, DEAR, BBX Lower
Unusual 11 Mid-Day Movers 1/25: SMTX, NBS, KFS, SILC, PVTB Higher; PARD, ZAGG, DEAR, BBX Lower
Recent Alert on 01/25/10 at 10:54am
Morning Movers 1/25: SMTX, NBS, ERI, KFS, PVTB, CADC Higher; PARD, SNEN, BBX, PCBC Lower
Morning Movers 1/25: SMTX, NBS, ERI, KFS, PVTB, CADC Higher; PARD, SNEN, BBX, PCBC Lower
Recent Alert on 01/25/10 at 10:50am
Notable Analyst Rating Changes 01/25: GD, SOLF, DRYS, EGLE, SAP Upgraded; PRSP, PARD, IGT, LPX, TSS Downgraded
Notable Analyst Rating Changes 01/25: GD, SOLF, DRYS, EGLE, SAP Upgraded; PRSP, PARD, IGT, LPX, TSS Downgraded
View AllRecent Press Releases
Press Release on 02/05/10 at 9:27am
Poniard Pharmaceuticals to Present at 12th Annual BIO CEO and Investor Conference
Poniard Pharmaceuticals to Present at 12th Annual BIO CEO and Investor Conference
View AllRecent SEC Filings
SEC Filing on 02/09/10 at 1:04pm
Form 4 PONIARD PHARMACEUTICALS, For: Feb 08 Filed by: JACKSON MICHAEL K
Form 4 PONIARD PHARMACEUTICALS, For: Feb 08 Filed by: JACKSON MICHAEL K
SEC Filing on 02/09/10 at 1:04pm
Form 4 PONIARD PHARMACEUTICALS, For: Feb 05 Filed by: JACKSON MICHAEL K
Form 4 PONIARD PHARMACEUTICALS, For: Feb 05 Filed by: JACKSON MICHAEL K
SEC Filing on 02/08/10 at 4:17pm
Form 4 PONIARD PHARMACEUTICALS, For: Feb 04 Filed by: WEAVER GREGORY L
Form 4 PONIARD PHARMACEUTICALS, For: Feb 04 Filed by: WEAVER GREGORY L
SEC Filing on 02/08/10 at 4:17pm
Form 4 PONIARD PHARMACEUTICALS, For: Feb 04 Filed by: JACKSON MICHAEL K
Form 4 PONIARD PHARMACEUTICALS, For: Feb 04 Filed by: JACKSON MICHAEL K
View AllRecent Blog Posts
Blog Posts on 02/08/10 at 4:14am
GlaxoSmithKline, Poniard, Protalix Provide Biotech's Latest Mishaps
GlaxoSmithKline, Poniard, Protalix Provide Biotech's Latest Mishaps
Blog Posts on 01/25/10 at 11:45am
Analyst Upgrades, Downgrades and Initiations: GD, ICE, IGT, SAP, STI, TMH, TSS ...
Analyst Upgrades, Downgrades and Initiations: GD, ICE, IGT, SAP, STI, TMH, TSS ...
Blog Posts on 01/11/10 at 4:04am
Poniard Pharmaceuticals: Oversold, Undervalued, Poised for Short Squeeze
Poniard Pharmaceuticals: Oversold, Undervalued, Poised for Short Squeeze

